Inventiva Strengthens Leadership Team Ahead of Expected Phase 3 Data Readout of Lanifibranor
Inventiva S.A. - American Depository Shares (IVA)
Company Research
Source: GlobeNewswire
Recruitment of Chief Financial Officer, Chief Legal Officer, and Chief People Officer reflects Inventiva’s organizational build-out as it advances toward potential commercialization.Axel-Sven Malkomes joins as Chief Financial Officer, bringing more than 30 years of investment banking and corporate leadership experience, including recently playing an instrumental role in CureVac’s acquisition by BioNTech.Susan Coles joins as Chief Legal Officer, bringing more than 25 years of experience guiding life science companies through growth and transformation.Pamela Herbster joins as Chief People Officer, bringing over 25 years of biopharmaceutical experience in developing human resource strategies and programs that elevate organizational performance and cultivate high-performing, people-centric cultures. Daix (France), New York (United States), April 22, 2026 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused on
Show less
Read more
Impact Snapshot
Event Time:
IVA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IVA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IVA alerts
High impacting Inventiva S.A. - American Depository Shares news events
Weekly update
A roundup of the hottest topics
IVA
News
- Inventiva (IVA) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=IVA&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" to "sellMarketBeat
- Inventiva announces filing of its 2025 Universal Registration Document and 2025 Annual Report on Form 20-FGlobeNewswire
- Inventiva reports 2025 full year results and provides a business updateGlobeNewswire
- Inventiva Schedules the Publication and Presentation of its 2025 Full-Year Financial Results GlobeNewswire
- Inventiva (IVA) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
IVA
Earnings
- 3/30/26 - Miss
IVA
Sec Filings
- 4/22/26 - Form 6-K
- 4/8/26 - Form 20-F
- 4/1/26 - Form SCHEDULE
- IVA's page on the SEC website